Market Share of Injectable Anti-diabetic Drugs Industry
The injectable anti-diabetic drugs market is consolidated, with major manufacturers, namely Eli Lilly, Novo Nordisk, and Sanofi, among others, holding a presence in all regions. Mergers and acquisitions that have happened between the players in the recent past helped the companies strengthen their market presence. For instance, Eli Lilly and Boehringer Ingelheim together have an alliance in developing and commercializing Basaglar (insulin glargine).
Injectable Anti-diabetic Drugs Market Leaders
-
Novo Nordisk
-
Lilly
-
Julphar
-
Biocon
-
Sanofi
*Disclaimer: Major Players sorted in no particular order
